MOLECULAR PARTNERS
Molecular Partners is a clinical-stage biopharmaceutical company working to advance modern medicine and significantly improve the management of serious diseases. They are developing a powerful new class of potent, specific and versatile small protein therapies called DARPin® therapeutics.
MOLECULAR PARTNERS
Industry:
Biotechnology Medical Pharmaceutical
Founded:
2004-01-01
Address:
Zürich, Zurich, Switzerland
Country:
Switzerland
Website Url:
http://www.molecularpartners.com
Total Employee:
51+
Status:
Active
Contact:
+41 44 755 77 00
Email Addresses:
[email protected]
Total Funding:
188.82 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
HUTCHMED (China) Limited
HUTCHMED (Nasdaq/AIM:HCM; HKEX:13) is an innovative, commercial-stage, biopharmaceutical company.
Ablaze Pharmaceuticals
Ablaze Pharmaceuticals is a clinical-stage pharmaceutical company.
Adrenomed
Adrenomed is a privately-financed, clinical-stage biopharmaceutical company.
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
Ascentage Pharma
Ascentage is a clinical-stage biopharmaceutical company that develops drugs for the treatment of cancer.
Aurealis Pharma
Aurealis Pharma is a biopharmaceutical company.
Basilea Pharmaceutica
Basilea Pharmaceutica Ltd. is a commercial stage biopharmaceutical company.
BioInvent
BioInvent is a research-based pharmaceutical company.
Biomics Biopharma
Biomics Biopharma is a clinical-stage biopharmaceutical company.
Caladrius Biosciences
Caladrius Biosciences is a clinical-stage biopharmaceutical company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Corvus Pharmaceuticals
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.
Diatech Pharmacogenetics
Diatech Pharmacogenetics is an Italian Precision Medicine company.
Exvastat
Exvastat is an innovative, preclinical-stage pharmaceutical company.
Frontier Biotechnologies
Frontier Biotechnologies is a commercial-stage bio-pharmaceutical company.
Halia Therapeutics
Halia is a preclinical-stage biopharmaceutical company.
Hope Medicine
Hope Medicine is a science-driven clinical stage biopharmaceutical company
Humanetics Corporation
clinical stage pharmaceutical company.
Kringle Pharma
Kringle Pharma is a biopharmaceutical company.
Leap Therapeutics
Leap Therapeutics is a clinical-stage biopharmaceutical company.
MediPrint Ophthalmics
MediPrint Ophthalmics is a clinical stage eye care pharmaceutical company.
Lipid Pharmaceuticals
Lipid Pharmaceuticals is a clinical-stage, privately held, pharmaceutical development company.
MetrioPharm
MetrioPharm is a clinical stage pharmaceutical development company.
Minerva Neuroscience
Minerva Neurosciences is a clinical-stage biopharmaceutical company
Novaremed AG
Novaremed AG is a clinical-stage Swiss biopharmaceutical company.
NuCana
NuCana is a clinical-stage biopharmaceutical company
Proveca
Proveca is a UK based pharmaceutical company.
SeQuent Scientific
SeQuent Scientific Limited is an India-based integrated pharmaceutical company.
UroGen Pharma
UroGen Pharma is a clinical-stage biopharmaceutical company focused on developing novel therapies.
Zelluna Immunotherapy
Zelluna Immunotherapy is a privately owned Norwegian biopharmaceutical company.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Novartis
Novartis investment in Post-IPO Equity - Molecular Partners
Federated Kaufmann Fund
Federated Kaufmann Fund investment in Post-IPO Equity - Molecular Partners
BVF Partners
BVF Partners investment in Post-IPO Equity - Molecular Partners
Camber Capital Corp
Camber Capital Corp investment in Post-IPO Equity - Molecular Partners
Suvretta Capital Management
Suvretta Capital Management investment in Post-IPO Equity - Molecular Partners
Endeavour Vision
Endeavour Vision investment in Series B - Molecular Partners
Johnson & Johnson Development Corporation
Johnson & Johnson Development Corporation investment in Series B - Molecular Partners
Index Ventures
Index Ventures investment in Series B - Molecular Partners
BB Biotech Ventures
BB Biotech Ventures investment in Series B - Molecular Partners
Essex Woodlands Healthcare Partners
Essex Woodlands Healthcare Partners investment in Series B - Molecular Partners
Official Site Inspections
http://www.molecularpartners.com Semrush global rank: 768.67 K Semrush visits lastest month: 51.76 K
- Host name: apollo-18524850-129.titandc.io
- IP address: 185.248.50.129
- Location: Spain
- Latitude: 40.4172
- Longitude: -3.684
- Timezone: Europe/Madrid
More informations about "Molecular Partners"
Molecular Partners | About Us
Prior to Immunogen, he was the Chief Medical Officer and head of the Medical and Scientific Organization at Flatiron Health, a healthcare technology and services company focused on …See details»
Molecular Partners Announces Planned Operational Efficiencies …
Jun 10, 2025 The strategic review was undertaken to identify certain redundancies within the organization, with a focus on research and associated functions. The company will report its …See details»
Partnering - Molecular Partners
Uniting therapeutic innovation with global capabilities We are called Molecular Partners for a reason. We believe strong external collaborations are an …See details»
News Release Details - investors.molecularpartners.com
May 15, 2025 Clinical programs on track, with two major milestones later this year, and cash position, CHF 131 million as of March 31, 2025, expected to provide funding well into 2027 …See details»
Clinical Trials Information for Patients - molecularpartners.com
Discover how to participate in Molecular Partners clinical trials. Get information about ongoing studies and connect with experts.See details»
Careers at Molecular Partners | Join Our Innovative …
Careers About our team As our name indicates, partnership and collaboration are at the core of our company, our research activities and our therapeutic …See details»
Contact Us - Molecular Partners
General inquiries [email protected] Media contacts Swiss Media: Laura Jeanbart, Ph.D. [email protected] Tel: +41 44 755 77 00 International Media: …See details»
Molecular Partners - Wikipedia
Molecular Partners AG is a clinical-stage biopharmaceutical company based in Zürich, Switzerland. [2] The company is developing a new class of potent, specific and versatile small …See details»
Molecular Partners AG – Swiss Biotech
Molecular Partners AG (SIX: MOLN, NASDAQ: MOLN) is a clinical-stage biotech company pioneering the design and development of a novel class of DARPin …See details»
Molecular Partners - Crunchbase Company Profile
Molecular Partners is a clinical-stage biopharmaceutical company.Where is Molecular Partners's headquarters? Molecular Partners is located in Zürich, …See details»
Molecular Partners Announces Scientific Leadership Transition …
Jun 11, 2019 Pamela A. Trail, Ph.D., to transition from Chief Scientific Officer to strategic consultant; Daniel Steiner, Ph.D., to assume leadership of research organization Zurich …See details»
Molecular Partners | LinkedIn
Molecular Partners AG is a clinical-stage biotech company pioneering the design and development of DARPin therapeutics, a new class of custom-built drugs for medical …See details»
Molecular Partners Finalizes License Agreement with Novartis for ...
The finalization of this agreement triggers a milestone payment of CHF 150 million to Molecular Partners. Under the license agreement announced today, Molecular Partners will be eligible to …See details»
Molecular Partners Company Profile - Office Locations ... - Craft
Oct 29, 2024 Molecular Partners is a biopharmaceutical company that focuses on the discovery, development, and commercialization of biopharmaceutical products for the treatment of wet …See details»
Molecular Partners Announces Planned Operational
Jun 10, 2025 The plan to right-size the organization extends our cash reach into 2028, supporting both the development of our clinical assets and advancement of new products into …See details»
Molecular Partners - LinkedIn
Molecular Partners AG is a clinical-stage biotech company pioneering the design and development of DARPin therapeutics, a new class of custom-built drugs for medical …See details»
Molecular Partners Announces all Board Proposals Approved at …
Apr 16, 2025 Molecular Partners AG (SIX: MOLN, NASDAQ: MOLN) is a clinical-stage biotech company pioneering the design and development of DARPin therapeutics for medical …See details»
Molecular Partners Announces Planned Operational Efficiencies …
Jun 10, 2025 The plan to right-size the organization extends our cash reach into 2028, supporting both the development of our clinical assets and advancement of new products into …See details»
Molecular Partners Reports Corporate Highlights and Key …
Molecular Partners advanced in 2021 with strong momentum for the Company’s lead antiviral candidate, ensovibep, which has progressed in the second quarter of 2021 into two ongoing, …See details»
Molecular Partners Reports Corporate Highlights From Q4 2021 …
This press release, the Company's Annual Report on Form 20-F for the year ended December 31, 2021 to be filed with the U.S. Securities and Exchange Commission (SEC), and the …See details»